Opaleye Management Inc. Ocular Therapeutix, Inc Transaction History

Opaleye Management Inc.

$508 Million
Q4 2024

A detailed history of Opaleye Management Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Opaleye Management Inc. holds 4,342,500 shares of OCUL stock, worth $32.5 Million. This represents 7.29% of its overall portfolio holdings.

Number of Shares

4,342,500

Previous 5,025,000 13.58%

Holding current value

$32.5 Million

Previous $43.7 Million 15.17%

% of portfolio

7.29%

Previous 7.98%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$8.33 - $11.47 $5.69 Million - $7.83 Million	-682,500 Reduced 13.58%	4,342,500 $37.1 Million
Q3 2024 Nov 14, 2024	SELL	$6.45 - $9.23 $1.82 Million - $2.61 Million	-282,500 Reduced 5.32%	5,025,000 $43.7 Million
Q2 2024 Aug 14, 2024	SELL	$4.2 - $8.69 $5.65 Million - $11.7 Million	-1,345,638 Reduced 20.23%	5,307,500 $36.3 Million
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $2.25 Million - $6.37 Million	583,138 Added 9.61%	6,653,138 $60.5 Million
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $827,840 - $1.8 Million	-398,000 Reduced 6.15%	6,070,000 $27.1 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $2.16 Million - $3.47 Million	688,000 Added 11.9%	6,468,000 $20.3 Million
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $1.5 Million - $2.49 Million	-325,900 Reduced 5.34%	5,780,000 $29.8 Million
Q1 2023 May 12, 2023	BUY	$2.79 - $6.27 $86,211 - $193,743	30,900 Added 0.51%	6,105,900 $32.2 Million
Q4 2022 Feb 10, 2023	SELL	$2.61 - $4.41 $1.02 Million - $1.72 Million	-390,000 Reduced 6.03%	6,075,000 $17.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $2 Million - $3.19 Million	490,200 Added 8.2%	6,465,000 $26.8 Million
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $3.11 Million - $6.1 Million	-505,200 Reduced 7.8%	5,974,800 $41.6 Million
Q1 2021 May 18, 2021	SELL	$15.82 - $22.11 $474,600 - $663,300	-30,000 Reduced 0.46%	6,480,000 $106 Million
Q4 2020 Feb 12, 2021	BUY	$7.91 - $22.95 $4.16 Million - $12.1 Million	525,800 Added 8.79%	6,510,000 $135 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $4.02 Million - $7.71 Million	861,700 Added 16.82%	5,984,200 $49.8 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $59,250 - $111,000	15,000 Added 0.29%	5,122,500 $25.4 Million
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.73 $5.99 Million - $11 Million	2,332,500 Added 84.05%	5,107,500 $20.2 Million
Q3 2019 Nov 14, 2019	SELL	$3.04 - $5.32 $532,000 - $931,000	-175,000 Reduced 5.93%	2,775,000 $8.44 Million
Q2 2019 Aug 14, 2019	BUY	$2.46 - $4.52 $2.58 Million - $4.75 Million	1,050,000 Added 55.26%	2,950,000 $13 Million
Q1 2019 May 15, 2019	BUY	$3.51 - $4.77 $6.67 Million - $9.06 Million	1,900,000 New	1,900,000 $7.54 Million
Q4 2018 Feb 14, 2019	SELL	$3.87 - $7.11 $3.1 Million - $5.69 Million	-800,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.42 - $6.99 $1.69 Million - $2.17 Million	-311,000 Reduced 27.99%	800,000 $5.5 Million
Q2 2018 Aug 14, 2018	BUY	$5.99 - $8.17 $6.65 Million - $9.08 Million	1,111,000 New	1,111,000 $7.5 Million

Others Institutions Holding OCUL

# of Institutions

186

Shares Held

136M

Call Options Held

284K

Put Options Held

156K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $576M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account

Opaleye Management Inc. Ocular Therapeutix, Inc Transaction History